Found: 9
Select item for more details and to access through your institution.
Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01657-6
- By:
- Publication type:
- Article
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.659065
- By:
- Publication type:
- Article
Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1180449
- By:
- Publication type:
- Article
H3 ubiquitination by NEDD4 regulates H3 acetylation and tumorigenesis.
- Published in:
- Nature Communications, 2017, v. 8, n. 3, p. 14799, doi. 10.1038/ncomms14799
- By:
- Publication type:
- Article
MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1324-8
- By:
- Publication type:
- Article
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 6971, doi. 10.2147/CMAR.S182852
- By:
- Publication type:
- Article
Resveratrol-4-O-D-(2'-galloyl)-glucopyranoside Isolated from Polygonum cuspidatum Exhibits Anti-Hepatocellular Carcinoma Viability by Inducing Apoptosis via the JNK and ERK Pathway.
- Published in:
- Molecules, 2014, v. 19, n. 2, p. 1592, doi. 10.3390/molecules19021592
- By:
- Publication type:
- Article
NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00511-9
- By:
- Publication type:
- Article
CD200<sup>+</sup> cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.abn5029
- By:
- Publication type:
- Article